Dr. Jonathan Friedberg, director of the Wilmot Cancer Institute, is making significant strides in the fight against cancer.
As the lead researcher of a recent clinical trial, Dr. Friedberg has helped to identify a new immunotherapy treatment, which has put 94% of Hodgkin lymphoma patients into remission.
This breakthrough could revolutionize the standard of care for Hodgkin lymphoma, a disease primarily affecting teenagers and young adults.
From the 1960s, when almost all patients diagnosed with Hodgkin lymphoma succumbed to the disease within a couple of years, the medical field has evolved to cure the majority of patients, even those in advanced stages.
The focus of the ongoing research is now shifting to minimize the side effects associated with this promising treatment.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected]